MA44545A1 - Procédé de production d'un dérivé de diphénylméthane - Google Patents
Procédé de production d'un dérivé de diphénylméthaneInfo
- Publication number
- MA44545A1 MA44545A1 MA44545A MA44545A MA44545A1 MA 44545 A1 MA44545 A1 MA 44545A1 MA 44545 A MA44545 A MA 44545A MA 44545 A MA44545 A MA 44545A MA 44545 A1 MA44545 A1 MA 44545A1
- Authority
- MA
- Morocco
- Prior art keywords
- production
- diphenylmethane derivative
- synthesis
- diphenylmethane
- derivative
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- CZZYITDELCSZES-UHFFFAOYSA-N diphenylmethane Chemical class C=1C=CC=CC=1CC1=CC=CC=C1 CZZYITDELCSZES-UHFFFAOYSA-N 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 238000003786 synthesis reaction Methods 0.000 abstract 2
- 102100037202 Sodium/myo-inositol cotransporter 2 Human genes 0.000 abstract 1
- 101710090560 Sodium/myo-inositol cotransporter 2 Proteins 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000001308 synthesis method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B51/00—Introduction of protecting groups or activating groups, not provided for in the preceding groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne un procédé amélioré de production d'un dérivé de diphénylméthane qui est efficace comme inhibiteur du cotransporteur du glucose dépendant du sodium (sglt), le procédé étant exécuté à l'aide d'un procédé de synthèse convergent dans lequel chaque groupe majeur est séparément synthétisé et ensuite couplé. Ainsi, comparativement à un procédé de synthèse linéaire présenté dans les documents existants, la voie de synthèse est compacte et le rendement peut être accru, et les facteu
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160075910 | 2016-06-17 | ||
| PCT/KR2017/006271 WO2017217792A1 (fr) | 2016-06-17 | 2017-06-15 | Procédé de production d'un dérivé de diphénylméthane |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| MA44545A1 true MA44545A1 (fr) | 2019-10-31 |
| MA44545B1 MA44545B1 (fr) | 2020-05-29 |
| MA44545B2 MA44545B2 (fr) | 2020-11-30 |
Family
ID=60664449
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA44545A MA44545B2 (fr) | 2016-06-17 | 2017-06-15 | Procédé de production d'un dérivé de diphénylméthane |
| MA50774A MA50774B1 (fr) | 2016-06-17 | 2017-06-15 | Procédé de production d'un dérivé de diphénylméthane |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA50774A MA50774B1 (fr) | 2016-06-17 | 2017-06-15 | Procédé de production d'un dérivé de diphénylméthane |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US10640496B2 (fr) |
| EP (2) | EP3473621B1 (fr) |
| JP (4) | JP6763978B2 (fr) |
| KR (2) | KR102233229B1 (fr) |
| CN (2) | CN109311861B (fr) |
| AU (1) | AU2017285813B2 (fr) |
| CA (2) | CA3026756C (fr) |
| CL (1) | CL2018003645A1 (fr) |
| CO (1) | CO2018014018A2 (fr) |
| DK (2) | DK3473621T3 (fr) |
| DO (1) | DOP2018000287A (fr) |
| EC (1) | ECSP19000185A (fr) |
| ES (2) | ES2898336T3 (fr) |
| HR (1) | HRP20211670T8 (fr) |
| HU (1) | HUE056428T2 (fr) |
| MA (2) | MA44545B2 (fr) |
| MX (2) | MX385640B (fr) |
| MY (1) | MY203941A (fr) |
| NZ (1) | NZ749398A (fr) |
| PE (2) | PE20190467A1 (fr) |
| PH (1) | PH12018550206A1 (fr) |
| PL (2) | PL3663292T3 (fr) |
| PT (2) | PT3473621T (fr) |
| RS (1) | RS62550B1 (fr) |
| SA (2) | SA521422474B1 (fr) |
| SG (2) | SG11201811154QA (fr) |
| SI (1) | SI3663292T1 (fr) |
| TN (1) | TN2018000437A1 (fr) |
| WO (1) | WO2017217792A1 (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102011054773A1 (de) | 2011-10-25 | 2013-04-25 | Vb Autobatterie Gmbh & Co. Kgaa | Anschlusspol für einen Akkumulator, Akkumulatorgehäuse und Maschine zur Herstellung eines Anschlusspols |
| WO2020036382A1 (fr) * | 2018-08-13 | 2020-02-20 | 주식회사 대웅제약 | Procédé de production d'intermédiaire utile pour la synthèse d'un inhibiteur de sglt |
| CN112341416A (zh) * | 2019-08-09 | 2021-02-09 | 天津津艺医药科技发展有限责任公司 | 一种制备苯并含氧脂杂环衍生物的方法 |
| CN115087649B (zh) | 2020-02-27 | 2024-07-05 | 株式会社大熊制药 | 用于合成sglt抑制剂的中间体和使用该中间体制备sglt抑制剂的方法 |
| WO2022051980A1 (fr) * | 2020-09-10 | 2022-03-17 | 广东莱佛士制药技术有限公司 | Procédé de synthèse destiné à la préparation d'un intermédiaire des inhibiteurs de sglt |
| CN112094253B (zh) * | 2020-09-10 | 2023-01-10 | 株式会社大熊制药 | 用于制备sglt抑制剂中间体的合成方法 |
| CN113200860B (zh) * | 2021-04-29 | 2024-07-30 | 爱斯特（成都）生物制药股份有限公司 | 一种sglt2抑制剂中间体的制备方法 |
| KR20230046784A (ko) * | 2021-09-30 | 2023-04-06 | 주식회사 대웅제약 | 이나보글리플로진을 포함하는 약학 조성물 |
| CN113801010A (zh) * | 2021-11-18 | 2021-12-17 | 山东诚创蓝海医药科技有限公司 | 一种5-溴-2-氯苯甲酸的制备方法 |
| CN113912487B (zh) * | 2021-11-23 | 2024-05-28 | 山东研峰新材料科技有限公司 | 一种2,5-双卤代苯甲酸的合成方法 |
| KR20230110001A (ko) | 2022-01-14 | 2023-07-21 | 주식회사 대웅제약 | Ssglt 저해제의 합성에 유용한 중간체의 제조 방법 |
| KR20240044190A (ko) | 2022-09-28 | 2024-04-04 | 주식회사 대웅제약 | 이나보글리플로진의 신규한 결정형 및 이의 제조방법 |
| KR20240044194A (ko) * | 2022-09-28 | 2024-04-04 | 주식회사 대웅제약 | 이나보글리플로진의 신규한 공결정 |
| EP4595957A1 (fr) | 2022-09-29 | 2025-08-06 | Daewoong Pharmaceutical Co., Ltd. | Composition pharmaceutique comprenant de l'énavogliflozine pour la prévention ou le traitement de maladies du vieillissement cardiovasculaire |
| WO2024076177A1 (fr) | 2022-10-05 | 2024-04-11 | 주식회사 대웅제약 | Composition pharmaceutique pour la prévention ou le traitement d'une néphropathie et/ou du diabète sucré, comprenant de l'énavogliflozine |
| KR20240099055A (ko) | 2022-12-21 | 2024-06-28 | 주식회사 대웅테라퓨틱스 | 이나보글리플로진을 포함하는 점안제 형태의 약학 조성물 |
| KR20240107660A (ko) | 2022-12-30 | 2024-07-09 | 주식회사 대웅제약 | 이나보글리플로진 및 메트포르민을 포함하는 약학 조성물 |
| KR102853437B1 (ko) * | 2024-11-13 | 2025-09-04 | 대웅바이오(주) | 연속반응 공정을 이용한 이나보글리플로진 합성방법 |
| KR102837948B1 (ko) * | 2024-11-13 | 2025-07-25 | 대웅바이오(주) | 분배 투입법을 도입한 연속반응 공정을 이용한 이나보글리플로진 합성방법 |
| KR102837941B1 (ko) * | 2024-11-13 | 2025-07-25 | 대웅바이오(주) | Inline quenching 공정을 도입한 연속반응 공정을 이용한 이나보글리플로진 합성방법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4966907A (en) * | 1988-08-12 | 1990-10-30 | Merck & Co., Inc. | 6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis |
| ES2531660T3 (es) * | 2003-08-01 | 2015-03-18 | Mitsubishi Tanabe Pharma Corporation | Compuestos novedosos que tienen actividad inhibidora frente a transportador de glucosa dependiente de sodio |
| PT2183263E (pt) | 2007-07-26 | 2012-01-11 | Lexicon Pharmaceuticals Inc | Processos e compostos úteis na preparação de inibidores do co-transportador 2 de glucose e sódio |
| TW201018695A (en) | 2008-07-30 | 2010-05-16 | Ferrer Int | 1,6-dihydro-2H-3-oxa-6-aza-as-indacene compounds |
| US8163704B2 (en) | 2009-10-20 | 2012-04-24 | Novartis Ag | Glycoside derivatives and uses thereof |
| WO2012041898A1 (fr) * | 2010-09-29 | 2012-04-05 | Celon Pharma Sp. Z O.O. | Combinaison de l'inhibiteur de sglt2 et d'un composé de sucre pour le traitement du diabète |
| ES2719656T3 (es) * | 2011-06-01 | 2019-07-11 | Green Cross Corp | Derivados de difenilmetano novedosos como inhibidores del SGLT2 |
| US9340521B2 (en) * | 2013-03-18 | 2016-05-17 | Green Cross Corporation | Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives |
| FR3017868A1 (fr) * | 2014-02-21 | 2015-08-28 | Servier Lab | Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2017
- 2017-06-15 CA CA3026756A patent/CA3026756C/fr active Active
- 2017-06-15 PE PE2018003162A patent/PE20190467A1/es unknown
- 2017-06-15 MA MA44545A patent/MA44545B2/fr unknown
- 2017-06-15 MA MA50774A patent/MA50774B1/fr unknown
- 2017-06-15 CA CA3081033A patent/CA3081033C/fr active Active
- 2017-06-15 MY MYPI2018002498A patent/MY203941A/en unknown
- 2017-06-15 CN CN201780036968.1A patent/CN109311861B/zh active Active
- 2017-06-15 ES ES20152959T patent/ES2898336T3/es active Active
- 2017-06-15 MX MX2018015647A patent/MX385640B/es unknown
- 2017-06-15 JP JP2018565754A patent/JP6763978B2/ja active Active
- 2017-06-15 SG SG11201811154QA patent/SG11201811154QA/en unknown
- 2017-06-15 PL PL20152959T patent/PL3663292T3/pl unknown
- 2017-06-15 AU AU2017285813A patent/AU2017285813B2/en active Active
- 2017-06-15 ES ES17813615T patent/ES2891825T3/es active Active
- 2017-06-15 SI SI201730944T patent/SI3663292T1/sl unknown
- 2017-06-15 PL PL17813615T patent/PL3473621T3/pl unknown
- 2017-06-15 HU HUE20152959A patent/HUE056428T2/hu unknown
- 2017-06-15 SG SG10201911782RA patent/SG10201911782RA/en unknown
- 2017-06-15 KR KR1020170075799A patent/KR102233229B1/ko active Active
- 2017-06-15 PT PT17813615T patent/PT3473621T/pt unknown
- 2017-06-15 DK DK17813615.6T patent/DK3473621T3/da active
- 2017-06-15 EP EP17813615.6A patent/EP3473621B1/fr active Active
- 2017-06-15 EP EP20152959.1A patent/EP3663292B1/fr active Active
- 2017-06-15 TN TNP/2018/000437A patent/TN2018000437A1/en unknown
- 2017-06-15 CN CN202110860586.9A patent/CN113651803B/zh active Active
- 2017-06-15 WO PCT/KR2017/006271 patent/WO2017217792A1/fr not_active Ceased
- 2017-06-15 NZ NZ749398A patent/NZ749398A/en unknown
- 2017-06-15 PT PT201529591T patent/PT3663292T/pt unknown
- 2017-06-15 MX MX2021008988A patent/MX392177B/es unknown
- 2017-06-15 DK DK20152959.1T patent/DK3663292T3/da active
- 2017-06-15 US US16/310,005 patent/US10640496B2/en active Active
- 2017-06-15 RS RS20211297A patent/RS62550B1/sr unknown
- 2017-06-15 PE PE2023002240A patent/PE20240590A1/es unknown
- 2017-06-15 HR HRP20211670TT patent/HRP20211670T8/hr unknown
-
2018
- 2018-12-15 SA SA521422474A patent/SA521422474B1/ar unknown
- 2018-12-15 SA SA518400666A patent/SA518400666B1/ar unknown
- 2018-12-17 CL CL2018003645A patent/CL2018003645A1/es unknown
- 2018-12-17 DO DO2018000287A patent/DOP2018000287A/es unknown
- 2018-12-17 PH PH12018550206A patent/PH12018550206A1/en unknown
- 2018-12-21 CO CONC2018/0014018A patent/CO2018014018A2/es unknown
-
2019
- 2019-01-04 EC ECSENADI2019185A patent/ECSP19000185A/es unknown
- 2019-08-30 US US16/557,180 patent/US10889574B2/en active Active
-
2020
- 2020-04-06 JP JP2020068458A patent/JP7352509B2/ja active Active
-
2021
- 2021-03-22 KR KR1020210036824A patent/KR102379584B1/ko active Active
- 2021-06-21 JP JP2021102648A patent/JP7669206B2/ja active Active
-
2023
- 2023-07-06 JP JP2023111632A patent/JP7773506B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA44545A1 (fr) | Procédé de production d'un dérivé de diphénylméthane | |
| DE602006006200D1 (de) | Antikörper gegen 25-hydroxyvitamin d | |
| MA33368B1 (fr) | Préparation de chlorhydrate de nalmefene à partir de naltrexone | |
| EA200801622A1 (ru) | Способ получения легких олефинов переработкой диметилового эфира и устройство для его осуществления | |
| MA30079B1 (fr) | Procede de synthese de ferri-succinylcaseine | |
| EP2418270A4 (fr) | Micro-algue appartenant au genre navicula, procédé pour la production d'huile par culture de la micro-algue, et huile collectée à partir de la micro-algue | |
| EP3889252A4 (fr) | Microsupport pour culture cellulaire, son procédé de production, et procédé de culture cellulaire l'utilisant | |
| WO2018220533A3 (fr) | Procédé de production d'un composé optiquement actif | |
| EP1942185A4 (fr) | Procédé de production d'un micro-organisme synthétiseur de caroténoïde et procédé pour la production de caroténoide | |
| EA202091466A1 (ru) | Синтез сокристалла 1:1:1 1-циано-2-(4-циклопропилбензил)-4-(-d-глюкопираноз-1-ил)бензола, l-пролина и воды | |
| EA201101626A1 (ru) | Бактерии с высокоэффективным метаболизмом | |
| CL2011000296A1 (es) | Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados. | |
| ATE526033T1 (de) | Verfahren für die kultur von sporozoea sp. in vitro und ihre anwendungen | |
| EA201200820A1 (ru) | Способ синтеза промежуточных продуктов, применимых для получения замещенных индазолов и азаиндазолов | |
| EP4063343A4 (fr) | Procédé de production d'alcool 3,5-dihydroxy-4-méthoxybenzylique à partir de plancton | |
| CA3156366A1 (fr) | Procede de production d'acides alcanesulfoniques | |
| EP1954134A4 (fr) | Procede de synthetisation de derive 2-phenyl-1h-phenantrho[9,10-d]imidazole | |
| FR3000641B1 (fr) | Nucleon pour la culture de perles et son procede de preparation | |
| EP3882339A4 (fr) | Procédé de production de cellules produisant de l'insuline | |
| IT202300020778A1 (it) | Impianto per la produzione di grafite espansa | |
| EP4108652A4 (fr) | Procédé de production d'un alcool | |
| EA202191385A1 (ru) | Способы осветления культур клеток | |
| MA38535A1 (fr) | Procédé de production d'acide 5-aminolévulinique ou d'un sel de celui-ci | |
| EA201300666A1 (ru) | Сырье, способ и установки для получения биотоплива | |
| BRPI0514000A (pt) | método para a produção de derivados de diarilcicloalquila |